跳至主要内容
临床试验/JPRN-UMIN000009272
JPRN-UMIN000009272已完成2 期

pilot study of hepatic arterial infusion chemotherapy with cisplatin for advanced hepatocellular carcinoma patients in Child-Pugh score 8,9 - Efficacy of TAI with cisplatin for HCC in Child-Pugh score8,9

Department of Gastroenterology and Metabolism,Hiroshima University Hospital0 个研究点目标入组 30 人开始时间: 2012年11月6日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 90years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) Severe arterio-portal or arterio-venous shunts in the liver 2) Patinets with difficulty with drug arrival to hepatic lesion 3) Other uncontrolled severe illness. a) With severe cardiac failure b) With severe renal function disease c) With active infectious disease except viral hepatitis. d) With active gastrointestinal hemorrhage e) With active other malignancies. f) With hepatic encephalopathy and severe mental disorder g) With clinically significant refractory ascites or pleural effusion 4) Allergic reaction to iodine contrast material, gadolinium contrast material, or platium containing agent. 5) A pregnant woman, or a woman suspected of pregnancy. 6) Patients who are concluded to be inappropriate to participate in this study by their physitians

研究者

发起方
Department of Gastroenterology and Metabolism,Hiroshima University Hospital

相似试验

pilot study of hepatic arterial infusion... | 临床试验